Coleman Christopher D, Kiel Jessica R, Guarneiri Liana L, Bell Marjorie, Wilcox Meredith L, Maki Kevin C, Unick Jessica L, Jonnalagadda Satya S
Department of Scientific and Clinical Affairs Medifast, Inc. Baltimore Maryland USA.
Midwest Biomedical Research Addison Illinois USA.
Obes Sci Pract. 2023 Nov 30;10(1):e724. doi: 10.1002/osp4.724. eCollection 2024 Feb.
There is substantial inter-individual variability in response to weight loss interventions and emerging evidence suggests that weight loss during the early weeks of an intervention may be predictive of longer-term weight loss. This secondary analysis of data from a commercial program therefore examined 1) the associations between early weight loss (i.e., week 4) with final visit weight loss and duration on the program, and 2) other predictors of lower weight loss at final visit.
Client charts of adults with overweight or obesity ( = 748) were analyzed. Clients were stratified into categories of weight loss at the week 4 (< and ≥2%, 3% and 4%) and final visits (< and ≥5% and 10%). Multivariate logistic regression was used to assess predictors of <5% and <10% final visit weight loss.
The odds ratios for losing <5% or <10% of weight at the final visit were higher (49.0 (95% CI: 13.84, 173.63) and 20.1 (95% CI: 6.96, 58.06)) for clients who lost <2% or <3% compared to those who lost ≥2% or ≥3% at week 4. Other predictors of not losing a clinically relevant amount of weight included female sex, use of higher calorie meal plans and shorter time in the program, among others. Those who lost ≥2% at week 4 also had a significantly greater percent program completion (109.2 ± 75.2% vs. 82.3 ± 82.4, < 0.01) compared with those who did not meet the 2% threshold.
Lower 4-week weight loss was identified as a strong predictor of not losing a clinically relevant amount of weight. These results may be useful for the early identification of individuals who can be targeted for additional counseling and support to aid in attaining weight loss goals.
个体对减肥干预措施的反应存在很大差异,新出现的证据表明,干预早期几周内的体重减轻可能预示着长期体重减轻情况。因此,对来自一个商业项目的数据进行的这项二次分析,考察了:1)早期体重减轻(即第4周)与最后一次访视时的体重减轻及项目持续时间之间的关联;2)最后一次访视时体重减轻较少的其他预测因素。
对748名超重或肥胖成年人的客户病历进行了分析。将客户按第4周时的体重减轻类别(<2%和≥2%、3%和4%)以及最后一次访视时的体重减轻类别(<5%和≥5%以及10%)进行分层。采用多因素逻辑回归来评估最后一次访视时体重减轻<5%和<10%的预测因素。
与第4周体重减轻≥2%或≥3%的客户相比,第4周体重减轻<2%或<3%的客户在最后一次访视时体重减轻<5%或<10%的优势比更高(分别为49.0(95%置信区间:13.84,173.63)和20.1(95%置信区间:6.96,58.06))。其他体重未减轻至临床相关水平的预测因素包括女性、采用热量更高的饮食计划以及参与项目的时间较短等。与未达到2%阈值的客户相比,第4周体重减轻≥2%的客户项目完成率也显著更高(分别为109.2±75.2%和82.3±82.4%,P<0.01)。
第4周体重减轻较少被确定为体重未减轻至临床相关水平的一个有力预测因素。这些结果可能有助于早期识别那些需要额外咨询和支持以实现减肥目标的个体对象。